# FDA EIR - Novo Nordisk A/S - March 25, 2024

Source: https://www.globalkeysolutions.net/records/eir/novo-nordisk-as/e5940682-7d77-485a-a366-11b1f33ca5dc

> FDA EIR for Novo Nordisk A/S on March 25, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Novo Nordisk A/S
- Inspection Date: 2024-03-25
- Product Type: Drugs
- Office Name: Office of Biological Product Operations

## Related Documents

- [483 - 2024-03-25](https://www.globalkeysolutions.net/records/483/novo-nordisk-as/da5518cf-dd42-4d5b-b2f7-bdbb6dd3182c)
- [MEMO - 2024-03-25](https://www.globalkeysolutions.net/records/memo/novo-nordisk-as/c64eef41-5e75-4ec1-8077-7d00df21947b)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/stefan-nielsen/26d381e5-bcc0-436b-8ddd-8abfbf61ed5d)
- [recipient](https://www.globalkeysolutions.net/people/mai-britt-hammer-frost-thomasen/32d1d2a1-b2e0-4804-9493-0ae74df4751d)
- [Ralph M. Bernstein](https://www.globalkeysolutions.net/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [Maxwell Korang-Yeboah](https://www.globalkeysolutions.net/people/maxwell-korang-yeboah/7fa70d10-c535-4754-aae2-9889bee6edf8)
- [Zachary Kraus](https://www.globalkeysolutions.net/people/zachary-kraus/9a85297e-4a21-49a6-a848-bc4a1e759f1a)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

Office: https://www.globalkeysolutions.net/offices/office-of-biological-product-operations/7cd31f11-825c-4508-b091-d659fdc63ad9